STAT3 and lung carcinoma: Whereas their activation in lung macrophages is associated with pulmonary inflammation, tumor progression, and poor survival of patients with lung cancer, deletion of either STAT3 or RelA from lung macrophages in mice represses protumorigenic but boosts antitumorigenic immunity and therefore suppresses lung tumorigenesis.